Table 2.
Patient | BRAF mutation | Type of Second Lung Cancer | Months Between |
---|---|---|---|
1 | G469A | Metachronous with KRAS G12D | 43 months |
2 | G469A | Metachronous with KRAS G13C | 15 months |
3 | V600E | Metachronous with KRAS G12V | 50 months |
4 | G469V | Synchronous with KRAS G12C | -- |
5 | V600E | Synchronous with KRAS G12C | -- |
6 | G469A | Synchronous with KRAS G12C | -- |